Ashray Gunjur

10PUBLICATIONS
108CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursMolecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 10, 2026
A Phase I and Biodistribution Study of Ifabotuzumab, a Humanized Agonistic EphA3-Targeted Antibody, in Patients with Recurrent Glioblastoma.

|Apr 24, 2026
Nivolumab and Ipilimumab Combination Treatment in Patients with Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer: Results from the Phase II MoST-CIRCUIT Trial.

|Dec 19, 2025
The molecular cartography of malignant and benign sebaceous tumours.

I Ferreira, O M Rueda, L van der Weyden

|Sep 11, 2025
Effects of CVA21, an Oncolytic Virus, in Combination with Pembrolizumab on Immunogenicity and the Tumor Microenvironment in Advanced NSCLC: A Phase I/II Trial.

Adithya Balasubramanian, Claire Marceaux, Sehrish Kanwal

|Aug 19, 2024
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance.

Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur

|Mar 01, 2024
A gut microbial signature for combination immune checkpoint blockade across cancer types.

Ashray Gunjur, Yan Shao, Timothy Rozday

Pageof 2

Frequent Collaborators

4 joint publications

David J Adams

3 joint publications

Hui Kong Gan

3 joint publications

Jodie Palmer

2 joint publications

Craig Underhill